AssetMark’s Jade Biosciences JBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding JBIO
AssetMark's JBIO Position: Q3 2026 in Review
AssetMark held its Jade Biosciences (JBIO) position steady in Q3 2026 at 1 share worth $14. The position accounts for ﹤0.01% of the portfolio, ranked #3754.
AssetMark first reported a position in JBIO in Q2 2025 and has held it in 6 quarters since. The position peaked at $22 in Q2 2026. 102 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.
- AssetMark held 1 share of Jade Biosciences worth $14 as of Q3 2026.
- AssetMark left its Jade Biosciences share count unchanged in Q3 2026.
- Jade Biosciences made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3754 holding.
- AssetMark first reported a position in Jade Biosciences in Q2 2025 and has held it in 6 quarters since.
- AssetMark's Jade Biosciences position peaked at $22 in Q2 2026.
- 102 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.